Delivery Order SPE2DB22D6029-SPE2DB25FLTQA

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,061.54 fixed-price delivery order is for the supply of DIOVAN HCT 320-25 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,078.22 firm fixed-price delivery order covers the supply of DIOVAN HCT 80-12.5 MG TABLET 90S, a cardiovascular medication. The award has an ultimate completion date of December 23, 2024 and is not associated with any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for pharmaceutical products provided by Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The $2,899.20 firm fixed-price delivery order covers the supply of Diovan HCT 320-25 mg tablets, with a period of performance through October 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,209.50 firm-fixed-price delivery order is for the supply of DIOVAN HCT 320-25 MG TABLET 90S, and has a completion date of September 4, 2024. The award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $5,996.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIOVAN HCT 320-25 MG TABLET 90S, a cardiovascular medication, with a completion date of November 6, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $7,698.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Diovan HCT 320-12.5 MG TAB 90S, with an ultimate completion date of September 21, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,092.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent company Cencora, Inc. The contract is a delivery order for 4558880765 DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The award has an ultimate completion date of October 26, 2022 and is a firm fixed-price contract. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award is a delivery order valued at $4,532.78 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DIOVAN HCT 320-25 MG TABLET 90S, a cardiovascular medication. This award is not designated as a set-aside contract. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The $4,239.96 firm-fixed-price delivery order is for the supply of DIOVAN HCT 160-25 MG TABLET 90S, a prescription medication. The contract has a period of performance through July 2024 and is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,459.65 delivery order contract is for the supply of Diovan HCT 160-25 mg tablets. The contract has a firm-fixed price and covers delivery through September 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTQA
    Delivery Order

This is a Firm Fixed Price Delivery Order federal contract award valued at $3,962.12, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DIOVAN HCT 320-25 MG TABLET 90S, a cardiovascular medication, with a performance period running through January 6, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. No set-aside designations were used for this specific contract award.

Generated 4/4/25, 9:58 AM